compass_positive_tagline-01.png
COMPASS Pathways granted two US patents
March 23, 2021 08:00 ET | COMPASS Pathfinder Ltd.
COMPASS Pathways granted two US patents London, UK – 23 March 2021     COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access...
compass_positive_tagline-01.png
COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020
March 09, 2021 07:00 ET | COMPASS Pathfinder Ltd.
Phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression (TRD) on track to report data by end of 2021First Centre of Excellence, a research facility and innovation...
compass_positive_tagline-01.png
COMPASS Pathways plc to announce fourth quarter and full year 2020 financial results on 9 March 2021
March 02, 2021 07:00 ET | COMPASS Pathfinder Ltd.
New York, March 02, 2021 (GLOBE NEWSWIRE) -- London, UK – 2 March 2021 COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based...
compass_positive_tagline-01.png
COMPASS Pathways plc to participate in Cowen's 41st Annual Health Care Conference
February 26, 2021 07:00 ET | Compass Pathways
New York, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) -- George Goldsmith, Chairman & CEO, to participate in Neuropsych Panel discussion  London, UK – 26 February 2021 COMPASS Pathways plc (Nasdaq:...
compass_positive_tagline-01.png
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
February 09, 2021 07:02 ET | Compass Pathways
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to develop new psychedelic...
compass_positive_tagline-01.png
COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy
February 03, 2021 07:00 ET | Compass Pathways
Formal and scalable methodology for psychological support in psilocybin therapyLondon, UK – 3 February 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
compass_positive_tagline-01.png
COMPASS Pathways plc to participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference
January 28, 2021 08:00 ET | Compass Pathways
London, UK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
compass_positive_tagline-01.png
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care
January 08, 2021 07:47 ET | Compass Pathways
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc...
compass_positive_tagline-01.png
COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences
January 06, 2021 07:30 ET | Compass Pathways
London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...
compass_positive_tagline-01.png
COMPASS Pathways plc announces financial results for third quarter 2020
November 12, 2020 07:02 ET | Compass Pathways
London, UK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- · Third quarter and post-period highlights:  -  Completed upsized initial public offering (IPO) on Nasdaq, raising $146.6...